康缘药业：2025年第一季度净利润8341.3万元，同比下降38.37%

Group 1 - The core point of the article is that Kangyuan Pharmaceutical (600557) reported a significant decline in both revenue and net profit for the first quarter of 2025 compared to the same period last year [1] Group 2 - The company's revenue for Q1 2025 was 878 million yuan, representing a year-on-year decrease of 35.38% [1] - The net profit for the same period was 83.41 million yuan, showing a year-on-year decline of 38.37% [1]